A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
Clinical trial NCT00490971 · COMPLETED
Trial details
- NCT number
- NCT00490971
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2010-04-01
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.